Swiss drugs industry supplier Lonza is in talks to buy over 51 percent stake in India's Aptuit Laurus in a deal valued at $77 million to $99 million, the Business Standard reported on Wednesday. (Reuters)
Comments are closed.
Subscribe
Post your messages.Please refrain from posting offensive messages. IndiaPE accepts no liability for the consequences of your reliance on these postings and messages.